Exeliom Biosciences: a new generation of microbiota-derived biotherapies
… a specific bacterium, Faecalibacterium prausnitzii (Fprau), was consistently absent in patients experiencing a relapse but present in those in remission. "That was the beginning of a long story that changed our lives. We … in the journal PNAS , and now cited more than 4,000 times, established for the first time the immunomodulatory …
Published on: